Skip to main content
Caplight Logo









AbelZeta Pharma

AbelZeta Pharma

Private
Rockville, MarylandHealthcare & Life Scienceshttps://www.abelzeta.com/

Last Round

Series A

Sep 30, 2021

Total Funding Raised

$120M

Company Overview

AbelZeta Pharma is a biopharmaceutical company that focuses on developing innovative and proprietary cell-based therapeutic products to treat hematological malignancies, solid tumors, and inflammatory and immunological diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

CAR-T therapycell therapyT-cell immunotherapyclinical stage biotechbiotech licensingautologous cell therapysolid tumor therapyautoimmune disease therapypharma partnershipsbi-specific CAR-Thematological cancerarmored CAR-Tchimeric antigen receptor T-cellGMP manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AbelZeta Pharma Comparables

Compare AbelZeta Pharma with similar companies based on industry and business-model similarity.

AbelZeta Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PersonGen BioTherapeutics
84%
Oricell Therapeutics
84%
Shanghai YaKe Biotechnology Co., Ltd.
82%

AbelZeta Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 30, 2021

AbelZeta Pharma Investors

Notable investors and investment history

AbelZeta Pharma investors
InvestorRounds
GIC Private LimitedSeries A
CICC CapitalSeries A
Yunfeng CapitalSeries A
HongShan Capital Group (HSG)Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 15, 2024

    Monthly visitors grew 33% MoM, reaching 2.4K.

  • Oct 30, 2024

    Monthly visitors increased 80% MoM.

AbelZeta Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AbelZeta Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AbelZeta Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersRockville, Maryland
Employee Range118
Year Founded2009
Last FundingSep 30, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?